Erythropoietin Decreases the Occurrence of Myocardial Fibrosis by Inhibiting the NADPH-ERK-NF-κB Pathway

Publisher: Karger

E-ISSN: 1421-9751|133|2|97-108

ISSN: 0008-6312

Source: Cardiology, Vol.133, Iss.2, 2016-0, pp. : 97-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content